There is a newer version of the record available.

Published January 10, 2026 | Version 1.0.0
Book chapter Open

The Risks of Antibiotic Resistance

Authors/Creators

  • 1. ROR icon Northern Technical University

Description

This document contains the cover page, abstract, and the first chapter of the book titled "The Risks of Antibiotic Resistance: A Comprehensive Study on Microbial Mechanisms and Global Health Impact". The full version of the book is officially published and registered with ISBN: 978-1-291-86534-9. This preview is intended for academic display and indexing purposes. The complete work is available through Lulu Press.

Files

Chapter 1 of The Risks of Antibiotic Resistance.pdf

Files (883.0 kB)

Additional details

Related works

Is part of
Book chapter: 978-1-291-86534-9 (ISBN)

Dates

Issued
2026-01-10
Initial publication on Lulu Press.

References

  • Davies, J., & Davies, D. (2010). Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews, 74(3), 417–433. https://doi.org/10.1128/MMBR.00016-10 Walsh, C. (2000). Molecular mechanisms that confer antibacterial drug resistance. Nature, 406(6797), 775–781. https://doi.org/10.1038/35021219 Murray, C. J., Ikuta, K. S., Sharara, F., et al. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399(10325), 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0 Andrews, J. M. (2001). Determination of minimum inhibitory concentrations. Journal of Antimicrobial Chemotherapy, 48(suppl_1), 5–16. https://doi.org/10.1093/jac/48.suppl_1.5 Blair, J. M., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. (2015). Molecular mechanisms of antibiotic resistance. Nature Reviews Microbiology, 13(1), 42–51. https://doi.org/10.1038/nrmicro3380 Munita, J. M., & Arias, C. A. (2016). Mechanisms of antibiotic resistance. Microbiology Spectrum, 4(2). https://doi.org/10.1128/microbiolspec.VMBF-0016-2015 Turnidge, J., & Paterson, D. L. (2007). Setting and revising antibacterial susceptibility breakpoints. Clinical Microbiology Reviews, 20(3), 391–408. https://doi.org/10.1128/CMR.00047-06 Silver, L. L. (2011). Challenges of antibacterial discovery. Clinical Microbiology Reviews, 24(1), 71–109. https://doi.org/10.1128/CMR.00030-10 Teillant, A., Gandra, S., Barter, D., Morgan, D. J., & Laxminarayan, R. (2015). Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. The Lancet Infectious Diseases, 15(12), 1429–1437. https://doi.org/10.1016/S1473-3099(15)00270-4 Laxminarayan, R., Duse, A., Wattal, C., et al. (2013). Antibiotic resistance—the need for global solutions. The Lancet Infectious Diseases, 13(12), 1057–1098. https://doi.org/10.1016/S1473-3099(13)70318-9 Friedman, N. D., Temkin, E., & Carmeli, Y. (2016). The negative impact of antibiotic resistance. Clinical Microbiology and Infection, 22(5), 416–422. https://doi.org/10.1016/j.cmi.2015.12.002 O'Neill, J. (2016). Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance. Mediavilla, J. R., Chen, L., Mathema, B., & Kreiswirth, B. N. (2012). Global epidemiology of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Current Opinion in Microbiology, 15(5), 588–595. https://doi.org/10.1016/j.mib.2012.08.003 Rodloff, A., Bauer, T., Ewig, S., Kujath, P., & Müller, E. (2008). Susceptible, intermediate, and resistant - the intensity of antibiotic action. Deutsches Ärzteblatt International, 105(39), 657–662. https://doi.org/10.3238/arztebl.2008.0657